423 related articles for article (PubMed ID: 7995956)
21. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
[TBL] [Abstract][Full Text] [Related]
22. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.
Feito MJ; Sánchez A; Oliver MA; Pérez-Caballero D; Rodríguez de Córdoba S; Albertí S; Rojo JM
Mol Immunol; 2007 Jul; 44(14):3571-9. PubMed ID: 17467801
[TBL] [Abstract][Full Text] [Related]
23. Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail.
Ho DK; Riva R; Kirjavainen V; Jarva H; Ginström E; Blom AM; Skurnik M; Meri S
J Immunol; 2012 May; 188(9):4450-9. PubMed ID: 22467648
[TBL] [Abstract][Full Text] [Related]
24. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion.
Dieudonné-Vatran A; Krentz S; Blom AM; Meri S; Henriques-Normark B; Riesbeck K; Albiger B
J Immunol; 2009 Jun; 182(12):7865-77. PubMed ID: 19494311
[TBL] [Abstract][Full Text] [Related]
25. Protein Arp and protein H from group A streptococci. Ig binding and dimerization are regulated by temperature.
Akerström B; Lindahl G; Björck L; Lindqvist A
J Immunol; 1992 May; 148(10):3238-43. PubMed ID: 1578147
[TBL] [Abstract][Full Text] [Related]
26. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
Courtney HS; Hasty DL; Dale JB
Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
[TBL] [Abstract][Full Text] [Related]
27. Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.
Gustafsson MC; Lannergård J; Nilsson OR; Kristensen BM; Olsen JE; Harris CL; Ufret-Vincenty RL; Stålhammar-Carlemalm M; Lindahl G
PLoS Pathog; 2013; 9(4):e1003323. PubMed ID: 23637608
[TBL] [Abstract][Full Text] [Related]
28. Human C4BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family.
Johnsson E; Thern A; Dahlbäck B; Hedén LO; Wikström M; Lindahl G
Adv Exp Med Biol; 1997; 418():505-10. PubMed ID: 9331704
[No Abstract] [Full Text] [Related]
29. Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae.
Pietikäinen J; Meri T; Blom AM; Meri S
Mol Immunol; 2010 Mar; 47(6):1299-305. PubMed ID: 20022381
[TBL] [Abstract][Full Text] [Related]
30. Analysis of plasminogen-binding M proteins of Streptococcus pyogenes.
Ringdahl U; Sjöbring U
Methods; 2000 Jun; 21(2):143-50. PubMed ID: 10816375
[TBL] [Abstract][Full Text] [Related]
31. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation.
Morfeldt E; Berggård K; Persson J; Drakenberg T; Johnsson E; Lindahl E; Linse S; Lindahl G
J Immunol; 2001 Oct; 167(7):3870-7. PubMed ID: 11564804
[TBL] [Abstract][Full Text] [Related]
32. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization.
Hair PS; Wagner SM; Friederich PT; Drake RR; Nyalwidhe JO; Cunnion KM
Mol Immunol; 2012 Apr; 50(4):253-61. PubMed ID: 22333221
[TBL] [Abstract][Full Text] [Related]
33. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP.
André I; Persson J; Blom AM; Nilsson H; Drakenberg T; Lindahl G; Linse S
Biochemistry; 2006 Apr; 45(14):4559-68. PubMed ID: 16584191
[TBL] [Abstract][Full Text] [Related]
34. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
Seya T; Nagasawa S; Atkinson JP
J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
[TBL] [Abstract][Full Text] [Related]
35. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
[TBL] [Abstract][Full Text] [Related]
36. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.
Ermert D; Shaughnessy J; Joeris T; Kaplan J; Pang CJ; Kurt-Jones EA; Rice PA; Ram S; Blom AM
PLoS Pathog; 2015 Jul; 11(7):e1005043. PubMed ID: 26200783
[TBL] [Abstract][Full Text] [Related]
37. Identification of different forms of human C4b-binding protein lacking beta-chain and protein S binding ability.
Hessing M; Kanters D; Hackeng TM; Bouma BN
Thromb Haemost; 1990 Oct; 64(2):245-50. PubMed ID: 2148654
[TBL] [Abstract][Full Text] [Related]
38. The streptococcal M protein: a highly versatile molecule.
Smeesters PR; McMillan DJ; Sriprakash KS
Trends Microbiol; 2010 Jun; 18(6):275-82. PubMed ID: 20347595
[TBL] [Abstract][Full Text] [Related]
39. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein.
Persson J; Beall B; Linse S; Lindahl G
PLoS Pathog; 2006 May; 2(5):e47. PubMed ID: 16733543
[TBL] [Abstract][Full Text] [Related]
40. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type.
Stenberg L; O'Toole P; Lindahl G
Mol Microbiol; 1992 May; 6(9):1185-94. PubMed ID: 1588817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
